Literature DB >> 1445862

Purification and characterization of the human stromelysin catalytic domain expressed in Escherichia coli.

Q Z Ye1, L L Johnson, D J Hupe, V Baragi.   

Abstract

Human stromelysin is a member of the matrix metalloproteinase family involved in connective tissue degradation. The stromelysin catalytic domain (SCD) lacking both propeptide and C-terminal fragment was expressed in Escherichia coli in soluble and insoluble forms. The insoluble SCD was refolded to the active form in high yield. The protein showed remarkable thermal stability and was able to cleave a thiopeptolide substrate and its natural substrate proteoglycan. The stable and active 20-kDa protein provides an opportunity to elucidate the structure as well as the mechanism of catalysis and inhibition for matrix metalloproteinases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445862     DOI: 10.1021/bi00160a038

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Thioredoxin fusion construct enables high-yield production of soluble, active matrix metalloproteinase-8 (MMP-8) in Escherichia coli.

Authors:  M L McNiff; E P Haynes; N Dixit; F P Gao; J S Laurence
Journal:  Protein Expr Purif       Date:  2016-02-23       Impact factor: 1.650

2.  Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.

Authors:  M Wang; X Qin; J S Mudgett; T A Ferguson; R M Senior; H G Welgus
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.

Authors:  S R Van Doren; A V Kurochkin; W Hu; Q Z Ye; L L Johnson; D J Hupe; E R Zuiderweg
Journal:  Protein Sci       Date:  1995-12       Impact factor: 6.725

4.  NMR and bioinformatics discovery of exosites that tune metalloelastase specificity for solubilized elastin and collagen triple helices.

Authors:  Mark O Palmier; Yan G Fulcher; Rajagopalan Bhaskaran; Vinh Q Duong; Gregg B Fields; Steven R Van Doren
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

5.  A single step purification for autolytic zinc proteinases.

Authors:  Erin M Wilfong; Ursala Locklear; Eric J Toone
Journal:  Bioorg Med Chem Lett       Date:  2009-11-05       Impact factor: 2.823

Review 6.  Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Authors:  J Thomas Peterson
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

7.  Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.

Authors:  F H Büttner; C E Hughes; D Margerie; A Lichte; H Tschesche; B Caterson; E Bartnik
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

8.  Nonnatural amino acid incorporation into the methionine 214 position of the metzincin Pseudomonas aeruginosa alkaline protease.

Authors:  Paula Walasek; John F Honek
Journal:  BMC Biochem       Date:  2005-10-12       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.